EditorialCreativeSportKollektionenVideos
Preise
0Anmelden

Visuelle Inhalte für Profis.
800 Mio.+ Bilder und Videos.

Content-Hub

  • Aktuelle Ereignisse
  • Bilder des Jahres
  • Sport
  • Editorial
  • Creative
  • Kollektionen
  • Videos

Angebote

  • Preise & Pakete
  • Aktionen
  • Enterprise
  • Newsletter
  • Blog
  • The Game Magazine

Services

  • Bildrecherche
  • Auftragsfotografie
  • API & FTP Push
  • my-picturemaxx
  • Partner werden

Unternehmen

  • Über IMAGO
  • Karriere
  • News

Hilfe-Center

  • FAQ
  • Kontakt
ImpressumNutzungsbedingungenLizenzinformationenDatenschutzDatenschutzeinstellungen
© 2026 IMAGO
CEPICBAPLABVPA
  5. Novavax arbeitet an Doppelimpfstoff gegen Grippe und Coronavirus, Archivbilder

Novavax arbeitet an Doppelimpfstoff gegen Grippe und Coronavirus, Archivbilder

10.05.2021

Die folgenden Fotos wurden von der IMAGO Bildredaktion zu diesem Thema für Sie ausgewählt. Für weitere Bilder nutzen Sie bitte die Suchfunktion.

Bilder in dieser Kollektion

  • April 27, 2021, Ukraine: In this photo illustration, silhouette of hands in medical gloves hold a medical syringe and a vial in front of Novavax logo. Ukraine - ZUMAs197 20210427_zab_s197_066 Copyright: xPavloxGoncharx

    April 27, 2021, Ukraine: In this photo illustration, silhouette of hands in medical gloves hold a medical syringe and a vial in front of Novavax logo. Ukraine - ZUMAs197 20210427_zab_s197_066 Copyright: xPavloxGoncharx

  • February 1, 2021, Asuncion, Paraguay: Illustration photo of logo of Novavax, Inc. (Nasdaq: NVAX), a biotechnology company, seen displayed on smartphone behind a syringe with needle in front of waving flag of the United States, the words coronavirus disease (COVID-19) and visual representation of virus. Novavax announced on Jan 28 that NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with a vaccine efficacy of 89.3%, in its Phase 3 clinical trial conducted in the United Kingdom Asuncion Paraguay - ZUMAc217 20210201_zip_c217_001 Copyright: xAndrexM.xChangx

    February 1, 2021, Asuncion, Paraguay: Illustration photo of logo of Novavax, Inc. (Nasdaq: NVAX), a biotechnology company, seen displayed on smartphone behind a syringe with needle in front of waving flag of the United States, the words coronavirus disease (COVID-19) and visual representation of virus. Novavax announced on Jan 28 that NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with a vaccine efficacy of 89.3%, in its Phase 3 clinical trial conducted in the United Kingdom Asuncion Paraguay - ZUMAc217 20210201_zip_c217_001 Copyright: xAndrexM.xChangx

  • Vaccine for COVID-19 and Novavax logo, in Prague, Czech Republic, April 5, 2021. (CTKxPhoto MartinxMacakxGregor) CTKPhotoF202104070986401

    Vaccine for COVID-19 and Novavax logo, in Prague, Czech Republic, April 5, 2021. (CTKxPhoto MartinxMacakxGregor) CTKPhotoF202104070986401

  • Symbolbild Coronaserum-Impfstoffdosen Corona-Impfstoff

    Symbolbild Coronaserum-Impfstoffdosen Corona-Impfstoff

  • March 2, 2021, Barcelona, Catalonia, Spain: In this photo illustration a medical syringe seen displayed in front of the Novavax logo. Barcelona Spain - ZUMAd159 20210302_zia_d159_005 Copyright: xThiagoxPrudenciox

    March 2, 2021, Barcelona, Catalonia, Spain: In this photo illustration a medical syringe seen displayed in front of the Novavax logo. Barcelona Spain - ZUMAd159 20210302_zia_d159_005 Copyright: xThiagoxPrudenciox

  • March 2, 2021, Barcelona, Catalonia, Spain: In this photo illustration a close up of a hand holding a medical syringe in front of the Novavax logo. Barcelona Spain - ZUMAd159 20210302_zia_d159_002 Copyright: xThiagoxPrudenciox

    March 2, 2021, Barcelona, Catalonia, Spain: In this photo illustration a close up of a hand holding a medical syringe in front of the Novavax logo. Barcelona Spain - ZUMAd159 20210302_zia_d159_002 Copyright: xThiagoxPrudenciox

  • Symbolbild Spritze mit Impfstoff gegen Covid-19. Corona-Impfung

    Symbolbild Spritze mit Impfstoff gegen Covid-19. Corona-Impfung

  • 03.02.2021, Symbolbild: Impfstoffe, Coronavirus-Vaccine von NOVAVAX 03.02.2021, Symbolbild: Impfstoffe 03.02.2021, Symbolbild: Impfstoffe

    03.02.2021, Symbolbild: Impfstoffe, Coronavirus-Vaccine von NOVAVAX 03.02.2021, Symbolbild: Impfstoffe 03.02.2021, Symbolbild: Impfstoffe

  • 03.02.2021, Symbolbild: Impfstoffe, Coronavirus-Vaccine von NOVAVAX 03.02.2021, Symbolbild: Impfstoffe 03.02.2021, Symbolbild: Impfstoffe

    03.02.2021, Symbolbild: Impfstoffe, Coronavirus-Vaccine von NOVAVAX 03.02.2021, Symbolbild: Impfstoffe 03.02.2021, Symbolbild: Impfstoffe

  • January 29, 2021, Gaithersburg, MD, United States: January 29, 2021 - Washington, DC, United States: Novavax corporate headquarters. Novavax is the creator of a vaccine for COVID-19. Gaithersburg United States - ZUMAb161 20210129_zap_b161_002 Copyright: xMichaelxBrochsteinx

    January 29, 2021, Gaithersburg, MD, United States: January 29, 2021 - Washington, DC, United States: Novavax corporate headquarters. Novavax is the creator of a vaccine for COVID-19. Gaithersburg United States - ZUMAb161 20210129_zap_b161_002 Copyright: xMichaelxBrochsteinx

  • November 21, 2020, Ukraine: In this photo illustration a medical syringe and a vial with COVID-19 coronavirus vaccine seen in front of the Novavax the U.S. vaccine development company logo. Ukraine - ZUMAs197 20201121_zaa_s197_259 Copyright: xPavloxGoncharx

    November 21, 2020, Ukraine: In this photo illustration a medical syringe and a vial with COVID-19 coronavirus vaccine seen in front of the Novavax the U.S. vaccine development company logo. Ukraine - ZUMAs197 20201121_zaa_s197_259 Copyright: xPavloxGoncharx

  • November 21, 2020, Ukraine: In this photo illustration a medical syringe and a vial with COVID-19 coronavirus vaccine seen in front of the Novavax the U.S. vaccine development company logo. Ukraine - ZUMAs197 20201121_zaa_s197_258 Copyright: xPavloxGoncharx

    November 21, 2020, Ukraine: In this photo illustration a medical syringe and a vial with COVID-19 coronavirus vaccine seen in front of the Novavax the U.S. vaccine development company logo. Ukraine - ZUMAs197 20201121_zaa_s197_258 Copyright: xPavloxGoncharx

  • Symbolbild Corona-Impfstoff der Firma NOVAVAX, Mann mit Spritze, Corona-Krise, Baden-Württemberg, Deutschland Coronavirus FOTOMONTAGE

    Symbolbild Corona-Impfstoff der Firma NOVAVAX, Mann mit Spritze, Corona-Krise, Baden-Württemberg, Deutschland Coronavirus FOTOMONTAGE

Kollektionen
Auswahl